<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01346189</url>
  </required_header>
  <id_info>
    <org_study_id>812701</org_study_id>
    <secondary_id>RC4AG039114</secondary_id>
    <nct_id>NCT01346189</nct_id>
  </id_info>
  <brief_title>A Trial of Behavioral Economic Interventions to Reduce Cardiovascular Disease (CVD) Risk</brief_title>
  <official_title>A Randomized Trial of Behavioral Economic Interventions to Reduce CVD Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Geisinger Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Harvard School of Public Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Carnegie Mellon University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Harvard Vanguard Medical Associates</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Using a 4-arm, cluster-randomized controlled trial, the investigators will test the
      effectiveness of different behavioral economic interventions in increasing statin use and
      reducing LDL cholesterol among patients with poor cholesterol control who are at very high
      risk for CVD. The investigators will test these approaches among primary care physicians and
      their patients at very high risk of CVD at Geisinger Health System and University of
      Pennsylvania outpatient clinics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiovascular disease (CVD) is the leading cause of death in the United States. Despite
      strong evidence that reducing low-density lipoproteins (LDL) with statins successfully lowers
      CVD risk, physicians under-prescribe statins, physicians fail to intensify treatment when
      indicated, and more than 50% of patients stop taking statins within one year of first
      prescription, though such therapy typically should be life-long. In this study, we will test
      the effectiveness of different behavioral economic interventions in increasing statin use and
      reducing LDL cholesterol among patients with poor cholesterol control who are at very high
      risk for CVD. The application of conceptual approaches from behavioral economics offers
      considerable promise in advancing health and health care. Pay for performance initiatives
      represent one such potential application, but one in which incorporating the underlying
      psychology of decision makers has not generally been done, and experimental tests have not
      been conducted. We will test these approaches among primary care physicians and their
      patients at very high risk of CVD at Geisinger Health System and University of Pennsylvania
      outpatient clinics. Using a 4-arm, cluster-randomized controlled trial, we aim to answer
      these questions: [1] How does the provision of provider incentives compare to the provision
      of patient incentives, to a combination of patient and provider incentives, or to no
      incentives at all? [2] Are results sustained after incentives and other interventions are
      withdrawn? [3] How do these approaches compare in implementation, acceptability, cost, and
      cost-effectiveness?
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in LDL From Baseline to 12 Months</measure>
    <time_frame>12 months</time_frame>
    <description>Change in LDL-C levels (mg/dL)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in LDL From Baseline to 15 Months</measure>
    <time_frame>15 months</time_frame>
    <description>Change in LDL-C levels (mg/dL) from baseline to 15 months</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">1503</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Physician Incentives</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>(with adherence feedback)
Quarterly payments to physician combined based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL with daily patient statin adherence information made available.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patient Incentives</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>(with adherence feedback)
Quarterly payments to patient based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physician and Patient Combined Incentives</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>(with adherence feedback)
Quarterly payments shared evenly by physician and patient based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL. Physicians will receive daily information about patients' statin adherence.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral Economic Intervention</intervention_name>
    <description>Various combinations of financial incentives to patients and providers.</description>
    <arm_group_label>Physician Incentives</arm_group_label>
    <arm_group_label>Patient Incentives</arm_group_label>
    <arm_group_label>Physician and Patient Combined Incentives</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Physicians: All primary care providers who have at least 5 patients who meet
             eligibility criteria will be eligible.

          -  Patients: 10-year CVD risk of between 10-20% who do not have an LDL below 140 mg/dl or
             10-year CVD risk of at least 20% (including those with preexisting CHD) who do not
             have an LDL below 120 mg/dl will be the primary inclusion criteria. We have chosen to
             include all patients meeting these inclusion criteria regardless of their reported
             adherence to statins, as there clearly is room for improvement in the LDL through a
             combination of physician and patient actions.

        Exclusion Criteria:

          -  Patients will be excluded if they have a known allergy or history of side effects to
             statins, will not or cannot give consent, or have a markedly shortened life expectancy
             (diagnosis of metastatic cancer, end-stage renal disease on dialysis, or dementia).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kevin Volpp, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Asch, MD, MBA</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Harvard Vanguard Medical Associates</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Health System</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unversity of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2011</study_first_submitted>
  <study_first_submitted_qc>April 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 2, 2011</study_first_posted>
  <results_first_submitted>September 21, 2017</results_first_submitted>
  <results_first_submitted_qc>October 31, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">December 6, 2017</results_first_posted>
  <last_update_submitted>October 31, 2017</last_update_submitted>
  <last_update_submitted_qc>October 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiovascular Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Physician Incentives</title>
          <description>(with adherence feedback)
Quarterly payments to physician combined based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL with daily patient statin adherence information made available.
Behavioral Economic Intervention: Various combinations of financial incentives to patients and providers.</description>
        </group>
        <group group_id="P2">
          <title>Patient Incentives</title>
          <description>(with adherence feedback)
Quarterly payments to patient based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL.
Behavioral Economic Intervention: Various combinations of financial incentives to patients and providers.</description>
        </group>
        <group group_id="P3">
          <title>Physician and Patient Combined Incentives</title>
          <description>(with adherence feedback)
Quarterly payments shared evenly by physician and patient based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL. Physicians will receive daily information about patients' statin adherence.
Behavioral Economic Intervention: Various combinations of financial incentives to patients and providers.</description>
        </group>
        <group group_id="P4">
          <title>Usual Care/Control</title>
          <description>No Intervention</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="433"/>
                <participants group_id="P2" count="358"/>
                <participants group_id="P3" count="346"/>
                <participants group_id="P4" count="366"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="417">433 patients (64 primary care physicians) included in analysis</participants>
                <participants group_id="P2" count="341">358 Patients (58 primary care physicians) included in analysis</participants>
                <participants group_id="P3" count="332">346 patients (58 primary care physicians) included in analysis</participants>
                <participants group_id="P4" count="355">366 patients (58 primary care physicians) included in analysis</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="14"/>
                <participants group_id="P4" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Moved</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Non-health system primary care physician</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Travel</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Physician Incentives</title>
          <description>(with adherence feedback)
Quarterly payments to physician combined based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL with daily patient statin adherence information made available.
Behavioral Economic Intervention: Various combinations of financial incentives to patients and providers.</description>
        </group>
        <group group_id="B2">
          <title>Patient Incentives</title>
          <description>(with adherence feedback)
Quarterly payments to patient based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL.
Behavioral Economic Intervention: Various combinations of financial incentives to patients and providers.</description>
        </group>
        <group group_id="B3">
          <title>Physician and Patient Combined Incentives</title>
          <description>(with adherence feedback)
Quarterly payments shared evenly by physician and patient based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL. Physicians will receive daily information about patients' statin adherence.
Behavioral Economic Intervention: Various combinations of financial incentives to patients and providers.</description>
        </group>
        <group group_id="B4">
          <title>Usual Care</title>
          <description>No Intervention</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="433"/>
            <count group_id="B2" value="358"/>
            <count group_id="B3" value="346"/>
            <count group_id="B4" value="366"/>
            <count group_id="B5" value="1503"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.68" spread="8.67"/>
                    <measurement group_id="B2" value="62.41" spread="8.63"/>
                    <measurement group_id="B3" value="62.03" spread="8.64"/>
                    <measurement group_id="B4" value="61.70" spread="8.89"/>
                    <measurement group_id="B5" value="61.99" spread="8.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="179"/>
                    <measurement group_id="B2" value="164"/>
                    <measurement group_id="B3" value="135"/>
                    <measurement group_id="B4" value="161"/>
                    <measurement group_id="B5" value="639"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="254"/>
                    <measurement group_id="B2" value="194"/>
                    <measurement group_id="B3" value="211"/>
                    <measurement group_id="B4" value="205"/>
                    <measurement group_id="B5" value="864"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>White, non-Hispanic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="360"/>
                    <measurement group_id="B2" value="265"/>
                    <measurement group_id="B3" value="285"/>
                    <measurement group_id="B4" value="289"/>
                    <measurement group_id="B5" value="1199"/>
                  </measurement_list>
                </category>
                <category>
                  <title>African American, non-Hispanic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="72"/>
                    <measurement group_id="B3" value="42"/>
                    <measurement group_id="B4" value="61"/>
                    <measurement group_id="B5" value="232"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other non-Hispanic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Hispanic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Missing</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Annual Household Income, No., $</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>&lt;50,000</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="193"/>
                    <measurement group_id="B2" value="145"/>
                    <measurement group_id="B3" value="134"/>
                    <measurement group_id="B4" value="163"/>
                    <measurement group_id="B5" value="635"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>50,000 to 100,000</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="144"/>
                    <measurement group_id="B2" value="129"/>
                    <measurement group_id="B3" value="126"/>
                    <measurement group_id="B4" value="124"/>
                    <measurement group_id="B5" value="523"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;100,000</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="85"/>
                    <measurement group_id="B2" value="76"/>
                    <measurement group_id="B3" value="68"/>
                    <measurement group_id="B4" value="68"/>
                    <measurement group_id="B5" value="297"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Education</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>&lt;College</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="148"/>
                    <measurement group_id="B2" value="107"/>
                    <measurement group_id="B3" value="102"/>
                    <measurement group_id="B4" value="129"/>
                    <measurement group_id="B5" value="486"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Some college</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="118"/>
                    <measurement group_id="B2" value="102"/>
                    <measurement group_id="B3" value="108"/>
                    <measurement group_id="B4" value="105"/>
                    <measurement group_id="B5" value="433"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>College and postcollege graduate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="165"/>
                    <measurement group_id="B2" value="148"/>
                    <measurement group_id="B3" value="133"/>
                    <measurement group_id="B4" value="131"/>
                    <measurement group_id="B5" value="577"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Marital Status</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Single</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="59"/>
                    <measurement group_id="B3" value="43"/>
                    <measurement group_id="B4" value="59"/>
                    <measurement group_id="B5" value="225"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Married</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="286"/>
                    <measurement group_id="B2" value="236"/>
                    <measurement group_id="B3" value="239"/>
                    <measurement group_id="B4" value="231"/>
                    <measurement group_id="B5" value="992"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="60"/>
                    <measurement group_id="B4" value="75"/>
                    <measurement group_id="B5" value="278"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Framingham Risk Score (FRS)</title>
          <description>The Framingham Risk Score is a gender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual. Individuals with low risk have 10% or less CHD risk at 10 years, with intermediate risk 10-20%, and with high risk 20% or more.</description>
          <units>%</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20.1" spread="9.0"/>
                    <measurement group_id="B2" value="19.7" spread="8.6"/>
                    <measurement group_id="B3" value="19.1" spread="8.7"/>
                    <measurement group_id="B4" value="20.1" spread="8.7"/>
                    <measurement group_id="B5" value="19.8" spread="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pre-existing coronary artery disease (CAD)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="143"/>
                    <measurement group_id="B2" value="110"/>
                    <measurement group_id="B3" value="115"/>
                    <measurement group_id="B4" value="148"/>
                    <measurement group_id="B5" value="516"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Taking cholesterol-reducing medications at baseline</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="166"/>
                    <measurement group_id="B2" value="180"/>
                    <measurement group_id="B3" value="200"/>
                    <measurement group_id="B4" value="166"/>
                    <measurement group_id="B5" value="712"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in LDL From Baseline to 12 Months</title>
        <description>Change in LDL-C levels (mg/dL)</description>
        <time_frame>12 months</time_frame>
        <population>Subjects were lost to follow-up, or withdrawn for other reasons. Thus the number analyzed at the 12 month time point does not equal the number analyzed during baseline.</population>
        <group_list>
          <group group_id="O1">
            <title>Physician Incentives</title>
            <description>(with adherence feedback)
Quarterly payments to physician combined based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL with daily patient statin adherence information made available.
Behavioral Economic Intervention: Various combinations of financial incentives to patients and providers.</description>
          </group>
          <group group_id="O2">
            <title>Patient Incentives</title>
            <description>(with adherence feedback)
Quarterly payments to patient based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL.
Behavioral Economic Intervention: Various combinations of financial incentives to patients and providers.</description>
          </group>
          <group group_id="O3">
            <title>Physician and Patient Combined Incentives</title>
            <description>(with adherence feedback)
Quarterly payments shared evenly by physician and patient based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL. Physicians will receive daily information about patients' statin adherence.
Behavioral Economic Intervention: Various combinations of financial incentives to patients and providers.</description>
          </group>
          <group group_id="O4">
            <title>Usual Care</title>
          </group>
        </group_list>
        <measure>
          <title>Change in LDL From Baseline to 12 Months</title>
          <description>Change in LDL-C levels (mg/dL)</description>
          <population>Subjects were lost to follow-up, or withdrawn for other reasons. Thus the number analyzed at the 12 month time point does not equal the number analyzed during baseline.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="433"/>
                <count group_id="O2" value="358"/>
                <count group_id="O3" value="346"/>
                <count group_id="O4" value="366"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Mean Reduction</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="433"/>
                    <count group_id="O2" value="358"/>
                    <count group_id="O3" value="346"/>
                    <count group_id="O4" value="366"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.9" lower_limit="24.9" upper_limit="31.0"/>
                    <measurement group_id="O2" value="25.1" lower_limit="21.6" upper_limit="28.5"/>
                    <measurement group_id="O3" value="33.6" lower_limit="30.1" upper_limit="37.1"/>
                    <measurement group_id="O4" value="25.1" lower_limit="21.7" upper_limit="28.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="433"/>
                    <count group_id="O2" value="358"/>
                    <count group_id="O3" value="346"/>
                    <count group_id="O4" value="366"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="159.9" lower_limit="157.4" upper_limit="162.5"/>
                    <measurement group_id="O2" value="160.6" lower_limit="157.6" upper_limit="163.0"/>
                    <measurement group_id="O3" value="160.1" lower_limit="157.3" upper_limit="163.3"/>
                    <measurement group_id="O4" value="161.5" lower_limit="159.0" upper_limit="164.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="396"/>
                    <count group_id="O2" value="329"/>
                    <count group_id="O3" value="317"/>
                    <count group_id="O4" value="331"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="132" lower_limit="127.8" upper_limit="135.3"/>
                    <measurement group_id="O2" value="135.5" lower_limit="130.8" upper_limit="138.9"/>
                    <measurement group_id="O3" value="126.4" lower_limit="123.1" upper_limit="130.1"/>
                    <measurement group_id="O4" value="136.4" lower_limit="132.5" upper_limit="140.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in LDL From Baseline to 15 Months</title>
        <description>Change in LDL-C levels (mg/dL) from baseline to 15 months</description>
        <time_frame>15 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Physician Incentives</title>
            <description>(with adherence feedback)
Quarterly payments to physician combined based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL with daily patient statin adherence information made available.
Behavioral Economic Intervention: Various combinations of financial incentives to patients and providers.</description>
          </group>
          <group group_id="O2">
            <title>Patient Incentives</title>
            <description>(with adherence feedback)
Quarterly payments to patient based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL.
Behavioral Economic Intervention: Various combinations of financial incentives to patients and providers.</description>
          </group>
          <group group_id="O3">
            <title>Physician and Patient Combined Incentives</title>
            <description>(with adherence feedback)
Quarterly payments shared evenly by physician and patient based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL. Physicians will receive daily information about patients' statin adherence.
Behavioral Economic Intervention: Various combinations of financial incentives to patients and providers.</description>
          </group>
          <group group_id="O4">
            <title>Usual Care</title>
          </group>
        </group_list>
        <measure>
          <title>Change in LDL From Baseline to 15 Months</title>
          <description>Change in LDL-C levels (mg/dL) from baseline to 15 months</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="433"/>
                <count group_id="O2" value="358"/>
                <count group_id="O3" value="346"/>
                <count group_id="O4" value="366"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.1" lower_limit="25.3" upper_limit="32.9"/>
                    <measurement group_id="O2" value="23.9" lower_limit="19.8" upper_limit="27.9"/>
                    <measurement group_id="O3" value="32.8" lower_limit="28.7" upper_limit="36.8"/>
                    <measurement group_id="O4" value="25.8" lower_limit="21.5" upper_limit="30.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected during the subjects' participation in the study; 15 month time period.</time_frame>
      <desc>Defining Adverse Events:
In this study, ALT greater than or equal to three times the upper limit of normal was considered an adverse event.
Defining Serious Adverse Events:
A definition for an SAE was assigned as ALT greater than or equal to 400 U/L, or hospitalizations or deaths caused by Myalgia or Rhabdomyolysis or liver toxicity.</desc>
      <group_list>
        <group group_id="E1">
          <title>Physician Incentives</title>
          <description>(with adherence feedback)
Quarterly payments to physician combined based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL with daily patient statin adherence information made available.
Behavioral Economic Intervention: Various combinations of financial incentives to patients and providers.</description>
        </group>
        <group group_id="E2">
          <title>Patient Incentives</title>
          <description>(with adherence feedback)
Quarterly payments to patient based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL.
Behavioral Economic Intervention: Various combinations of financial incentives to patients and providers.</description>
        </group>
        <group group_id="E3">
          <title>Physician and Patient Combined Incentives</title>
          <description>(with adherence feedback)
Quarterly payments shared evenly by physician and patient based on patient achieving an LDL reduction of at least 10 mg/dl relative to baseline LDL or the last quarter's target LDL. Physicians will receive daily information about patients' statin adherence.
Behavioral Economic Intervention: Various combinations of financial incentives to patients and providers.</description>
        </group>
        <group group_id="E4">
          <title>Usual Care/Control</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="433"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="358"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="346"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="366"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="433"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="358"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="346"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="366"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Pancreatic mass</sub_title>
                <description>Follow up CT scan revealed a large pancreatic obstructing mass compressing the common bile duct. With this clinical picture, this is the most likely cause for the transaminase elevation, and not statin related, as verified by subject's PCP</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="433"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="358"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="346"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="366"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="433"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="358"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="346"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="366"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Elevated Alanine Aminotransferase (ALT)</sub_title>
                <description>Elevated ALT lab result. ALT was determined by subject's PCP to not be study related; but rather due to methotrexate medication, which was stopped.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="433"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="358"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="346"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="366"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Patients in the control group received electronic pill bottles and may have been more adherent than is typical; Mean of about 6 patients per physician enrolled, limiting total size of potential reward; Adherence info came from pill bottle opening</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Kevin G. Volpp</name_or_title>
      <organization>University of Pennsylvania and Department of Veteran Affairs</organization>
      <email>volpp70@wharton.upenn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

